{"id":338867,"date":"2017-04-20T19:30:26","date_gmt":"2017-04-20T11:30:26","guid":{"rendered":"http:\/\/techcrunch.com\/?p=1479053"},"modified":"2017-04-20T19:30:26","modified_gmt":"2017-04-20T11:30:26","slug":"zapprx-gets-25-million-from-chinese-vcs-to-expand-into-the-u-s-drug-prescription-market","status":"publish","type":"post","link":"https:\/\/people.utm.my\/asmawisham\/zapprx-gets-25-million-from-chinese-vcs-to-expand-into-the-u-s-drug-prescription-market\/","title":{"rendered":"ZappRX gets $25 million from Chinese VC\u2019s to expand into the U.S. drug prescription market"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/tctechcrunch2011.files.wordpress.com\/2017\/04\/zoe-barry-zapprx-ceo-e1492647257388.jpg?w=738\" class=\"\"\/><\/p>\n<p id=\"speakable-summary\">ZappRX, the app that aims to make it easier to manage specialty drug prescriptions, has pulled in $25 million in Series B funding led by Qiming US, the Chinese venture outfit\u2019s stateside health care fund.<\/p>\n<p>GV (formerly Google Ventures) and GlaxoSmithKline\u2019s funding arm SR One were also in the round and GV\u2019s Krishna Yeshwant and Qiming US\u2019s Mark McDade will now join the board.<\/p>\n<p>ZappRx solves a unique dilemma in the prescription medication industry for doctors and pharmacists who treat conditions like oncology and pulmonology by getting rid of the paperwork. Many pharmacies still use fax or phone to transfer medical prescription information from the doctor, delaying the process and making it easy to make mistakes. ZappRx solves that by automating the process via an app which can process the information in real-time.<\/p>\n<p>The startup\u2019s platform is already being used in several top academic medical centers and multi-specialty practices in the U.S. and founders The new funding will help the company have the cash to expand in a fast-growing and potentially <a target=\"_blank\" href=\"http:\/\/www.imshealth.com\/en\/about-us\/news\/ims-health-study-us-drug-spending-growth-reaches-8.5-percent-in-2015\" rel=\"noopener noreferrer\">$400 billion<\/a> market in the next few years and ensures ZappRX gets in on the <a target=\"_blank\" href=\"http:\/\/www.imshealth.com\/en\/about-us\/news\/ims-health-study-us-drug-spending-growth-reaches-8.5-percent-in-2015\" rel=\"noopener noreferrer\">worldwide trend<\/a> towards the modernization of health care. It will also enable the company to hire engineers, business development managers and to forge partnerships in order to grow.<\/p>\n<p>So what\u2019s next? Founder Zoe Barry says she couldn\u2019t talk about any deals happening just yet but that she is in talks to work with all three of the big specialty pharmacies and tells TechCrunch the goal is \u201cto create essentially what is the Kayak meets Amazon one click of a disease platform\u201d \u2014 or in other words, getting through the drug purchase process as quickly as possible and at the best price.<\/p>\n<p>The startup previously raised $8.8 million, bringing the total funding now to $33.8 million.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"680\" height=\"531\" src=\"https:\/\/tctechcrunch2011.files.wordpress.com\/2017\/04\/zoe-barry-zapprx-ceo-e1492647257388.jpg?w=680\" class=\"attachment-large size-large wp-post-image\" alt=\"\" srcset=\"https:\/\/tctechcrunch2011.files.wordpress.com\/2017\/04\/zoe-barry-zapprx-ceo-e1492647257388.jpg?w=680 680w, https:\/\/tctechcrunch2011.files.wordpress.com\/2017\/04\/zoe-barry-zapprx-ceo-e1492647257388.jpg?w=1360 1360w, https:\/\/tctechcrunch2011.files.wordpress.com\/2017\/04\/zoe-barry-zapprx-ceo-e1492647257388.jpg?w=150 150w, https:\/\/tctechcrunch2011.files.wordpress.com\/2017\/04\/zoe-barry-zapprx-ceo-e1492647257388.jpg?w=300 300w, https:\/\/tctechcrunch2011.files.wordpress.com\/2017\/04\/zoe-barry-zapprx-ceo-e1492647257388.jpg?w=768 768w\" sizes=\"(max-width: 680px) 100vw, 680px\" \/>&nbsp;ZappRX, the app that aims to make it easier to manage specialty drug prescriptions, has pulled in $25 million in Series B funding led by Qiming US, the Chinese venture outfit&#8217;s stateside health care fund. GV (formerly Google Ventures) and GlaxoSmithKline&#8217;s funding arm SR One were also in the round and GV&#8217;s Krishna Yeshwant and Qiming US&#8217;s Mark McDade will now join&hellip; <a href=\"https:\/\/techcrunch.com\/2017\/04\/20\/zapprx-gets-25-million-from-chinese-vcs-hoping-to-tap-into-the-u-s-drug-prescription-market\/?ncid=rss\">Read More<\/a><\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=zCQTu3Sze1I:WORcXfkVwUM:2mJPEYqXBVI\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=2mJPEYqXBVI\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=zCQTu3Sze1I:WORcXfkVwUM:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=7Q72WNTAKBA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=zCQTu3Sze1I:WORcXfkVwUM:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=zCQTu3Sze1I:WORcXfkVwUM:-BTjWOF_DHI\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?i=zCQTu3Sze1I:WORcXfkVwUM:-BTjWOF_DHI\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=zCQTu3Sze1I:WORcXfkVwUM:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?i=zCQTu3Sze1I:WORcXfkVwUM:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=zCQTu3Sze1I:WORcXfkVwUM:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=qj6IDK7rITs\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Techcrunch\/~4\/zCQTu3Sze1I\" height=\"1\" width=\"1\" alt=\"\"\/> <\/p>\n","protected":false},"author":5817,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[25],"tags":[59,66,26],"class_list":["post-338867","post","type-post","status-publish","format-standard","hentry","category-technology","tag-media","tag-techcrunch","tag-technology"],"_links":{"self":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts\/338867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/users\/5817"}],"replies":[{"embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/comments?post=338867"}],"version-history":[{"count":0,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts\/338867\/revisions"}],"wp:attachment":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/media?parent=338867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/categories?post=338867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/tags?post=338867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}